Janice Pogue

Statistics and Probability · 2000–2016

A researcher in the Science corpus: 26 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Statistics and Probability — 5 citations into it

Whom Janice Pogue trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. David Firth

Who trusts Janice Pogue overall

1. V. Basevi
2. Gregory Y. H. Lip
3. Peter Libby

Papers from Janice Pogue's perspective

Ordered by how strongly the researchers Janice Pogue trusts endorse each paper. Same corpus, a different order for every researcher.

1. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
2. An estimation of the global volume of surgery: a modelling strategy based on available data. (The Lancet)
3. Population trends in the incidence and outcomes of acute myocardial infarction. (New England Journal of Medicine)
4. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. (Circulation)
5. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. (The Lancet)
6. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. (The Lancet)
7. 1. Overcoming the Reference Category Problem in the Presentation of Statistical Models
8. A Coefficient of Agreement for Nominal Scales
9. Regression Shrinkage and Selection via the Lasso
10. Statistical Analysis of Non-Lattice Data

Their papers

• Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. (2005) — 1,212 citations
• Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. (2006) — 1,710 citations
• Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. (2016) — 744 citations
• Randomized trial of primary PCI with or without routine manual thrombectomy. (2015) — 616 citations
• Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy. (2015) — 910 citations
• Aspirin in patients undergoing noncardiac surgery. (2014) — 791 citations
• Basal insulin and cardiovascular and other outcomes in dysglycemia. (2012) — 1,065 citations
• Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery (2011) — 630 citations
• Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. (2010) — 997 citations
• Effect of clopidogrel added to aspirin in patients with atrial fibrillation. (2009) — 1,867 citations
• Dabigatran versus warfarin in patients with atrial fibrillation. (2009) — 9,875 citations
• Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. (2008) — 2,045 citations
• Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. (2008) — 1,535 citations
• Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. (2008) — 890 citations
• Telmisartan, ramipril, or both in patients at high risk for vascular events. (2008) — 3,508 citations
• Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range (2008) — 932 citations
• Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. (2007) — 1,095 citations
• Comparison of fondaparinux and enoxaparin in acute coronary syndromes. (2006) — 1,144 citations
• Effect of ramipril on the incidence of diabetes. (2006) — 649 citations
• Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. (2006) — 870 citations